Study Questions Validity of Stroke Quality Measure

A study published in Neurology calls into question the validity of a quality measure that measures 30-day risk-adjusted stroke mortality.

Advertisement

 

The measure is currently being developed for use under healthcare reform, but hospitals have already adopted the measure to demonstrate their performance and quality of services. The study evaluated 436 stroke patients admitted to Strong Memorial Hospital in Rochester, N.Y., in 2009 with a diagnosis of ischemic stroke. Of that number, 37 (7.8 percent) either died within 30 days while in the hospital or were discharged to hospice care. Of that number, 36 patients died because of a decision by the patient or family to withhold or withdraw life-sustaining interventions.

The study authors then asked a panel of neurologists to determine whether deceased patients would have survived longer than 30 days if every available medical intervention were employed on a continuous basis. The panel determined that 41 percent of the patients could have been kept alive, effectively reducing the hospital’s mortality rate by 3.2 percent.

More Articles on Quality:

Winning Skeptics Over to Hospitals’ Quality Initiatives

3 Tips for Publicly Reporting Quality Data From Aligning Forces for Quality

CMS Extends Deadline for State Innovation Models Initiative

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.